AMNEAL PHARMS LLC FDA Approval ANDA 203133

ANDA 203133

AMNEAL PHARMS LLC

FDA Drug Application

Application #203133

Documents

Review2021-09-24

Application Sponsors

ANDA 203133AMNEAL PHARMS LLC

Marketing Status

Over-the-counter001

Application Products

001SUSPENSION, EXTENDED RELEASE;ORALEQ 30MG HYDROBROMIDE/5ML0DEXTROMETHORPHAN POLISTIREXDEXTROMETHORPHAN POLISTIREX

FDA Submissions

UNKNOWN; ORIG1AP2017-07-28

Submissions Property Types

ORIG1Null17

CDER Filings

AMNEAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203133
            [companyName] => AMNEAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"DEXTROMETHORPHAN POLISTIREX","activeIngredients":"DEXTROMETHORPHAN POLISTIREX","strength":"EQ 30MG HYDROBROMIDE\/5ML","dosageForm":"SUSPENSION, EXTENDED RELEASE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/28\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-07-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.